HCW Biologics Inc. (HCWB)
NASDAQ: HCWB
· Real-Time Price · USD
4.15
-0.19 (-4.38%)
At close: Aug 15, 2025, 3:59 PM
4.25
2.38%
After-hours: Aug 15, 2025, 07:39 PM EDT
HCW Biologics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M | -5.07M | -5.42M | -3.91M | -3.51M | -2.06M | -3.17M | -4.09M | -2.75M | -2.84M |
Depreciation & Amortization | 419.01K | 682.51K | 128.45K | 129.93K | 243.5K | 274.55K | 277.45K | 284.33K | 298.85K | 261.16K | 164.33K | 149.58K | 142.78K | 95.58K | 124.12K | 165.09K | 158.81K |
Stock-Based Compensation | 275.64K | 292.07K | 232.43K | 239.82K | 244.69K | 261.27K | 219.85K | 263.42K | 259.21K | 286.19K | 302.32K | 271.33K | 260.35K | 360.98K | 1.66K | n/a | n/a |
Other Working Capital | n/a | 2.58K | 125.24K | 401.17K | 246.1K | 599.67K | -283.69K | -5.56M | 103.07K | 589.53K | -48.17K | 445.54K | 1.37M | -2.5M | 41.16M | 5.88M | -150.36K |
Other Non-Cash Items | n/a | 292.07K | 232.43K | n/a | -2.4M | 5.66M | -627 | -627 | -112.29K | -66.55K | 627.00 | 24.84K | 185.33K | 1.46M | -221.53K | -1.68M | -567.31K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -409.5K | -40.63K | -110.94K | n/a | n/a | n/a | n/a | n/a | -1.36M | n/a | n/a | n/a |
Change in Working Capital | n/a | -436.19K | 614.93K | 10.05M | 3.38M | 1M | -1.11M | -5.52M | 986.71K | 1.15M | 1.09M | 374.97K | -123.42K | -753.84K | -1.15M | 1.59M | 1.76M |
Operating Cash Flow | -3.51M | -2.83M | -2.93M | -4.86M | -3.6M | -3.89M | -5.59M | -9.39M | -3.64M | -3.79M | -2.31M | -2.69M | -1.59M | -3.38M | -5.12M | -990.44K | -1.49M |
Capital Expenditures | n/a | -113.41K | -37.06K | 18.57K | -129.71K | -3.72M | -630.05K | -1.56M | -300.38K | -68.69K | -10.17M | -12.91K | -23.55K | -19.85K | -4.13K | n/a | -23.28K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.05K | -34.97M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 10M | n/a | n/a | 8M | 16.98M | n/a | 8M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 10M | n/a | n/a | -8M | 16.98M | n/a | 8M | -4.05K | -34.97M | n/a | n/a |
Investing Cash Flow | n/a | -113.41K | -37.06K | 18.57K | -129.71K | -3.72M | 9.37M | -1.56M | -300.38K | -68.69K | 6.81M | -12.91K | 7.98M | -23.9K | -34.97M | n/a | -23.28K |
Debt Repayment | n/a | 463.39K | 2.8M | 1.92M | 1.72M | -29.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.82M | n/a | n/a | n/a |
Other Financial Acitivies | -54.76K | 2.32M | n/a | n/a | 2.5M | n/a | -8.98K | n/a | n/a | -45.68K | 6.3M | n/a | n/a | n/a | -5.84M | -824.31K | -100K |
Financial Cash Flow | -53.1K | 6.62M | 2.8M | 1.92M | 4.22M | -15.25K | -8.9K | 7.71K | 1.9K | -39.85K | 6.3M | 6K | 2.27K | 6.1K | 50.16M | -814.85K | -86.61K |
Net Cash Flow | -3.57M | 3.68M | -163.09K | -2.92M | 488.97K | -7.63M | 3.77M | -10.94M | -3.94M | -3.9M | 10.8M | -2.7M | 6.39M | -3.39M | 10.07M | -1.81M | -1.6M |
Free Cash Flow | -3.51M | -2.95M | -2.96M | -4.84M | -3.73M | -7.61M | -6.22M | -10.95M | -3.94M | -3.86M | -12.48M | -2.7M | -1.62M | -3.4M | -5.12M | -990.44K | -1.51M |